Sanofi-Aventis Puts Growing Pains Aside, Prepares To Re-Enter M&A Fray
Executive Summary
Sanofi-Aventis' merger and acquisition strategy going forward will focus on mid-sized companies
You may also be interested in...
Sanofi Tries To Quash Bristol Rumors; M&A Efforts Center On Biotech, Japan
Sanofi-Aventis' merger and acquisition efforts will focus on biotech firms and Japanese companies, CEO Gerard Le Fur maintained Feb. 13
Sanofi Tries To Quash Bristol Rumors; M&A Efforts Center On Biotech, Japan
Sanofi-Aventis' merger and acquisition efforts will focus on biotech firms and Japanese companies, CEO Gerard Le Fur maintained Feb. 13
Sanofi Tries To Quash Bristol Rumors; M&A Efforts Center On Biotech, Japan
Sanofi-Aventis' merger and acquisition efforts will focus on biotech firms and Japanese companies, CEO Gerard Le Fur maintained Feb. 13